Full-Time

Associate Director/Director

Tempus

Tempus

1,001-5,000 employees

AI-driven precision medicine through clinical and molecular data analysis

Data & Analytics
AI & Machine Learning

Senior, Expert

Chicago, IL, USA

Requirements
  • Master’s degree with 10+ years experience or Ph.D. with 5+ years experience in molecular techniques
  • Strong analytical and conceptual capabilities, interpersonal skills, and ability to communicate with clarity
  • Highly organized and systematic, superb attention to detail, and ability to complete tasks with a high degree of accuracy
  • Track record of assay and/or product development
  • Hands-on experience with NGS library preparation methods, liquid biopsy in oncology space, PCR methods, nucleic acid ligations, nucleic acid analysis, magnetic bead-based DNA/RNA purification and size selection, MLPA, Sanger Sequencing, DNA hybridization arrays
  • Experience with robotics and automated liquid handling systems
  • Experience in validation of clinical assay validation
  • Knowledge of LIMS platforms and various computer systems
  • Experience developing and validating assays according to various US and international regulatory body requirements
Responsibilities
  • Lead a development and validation team from project inception through launch
  • Ensure activities are consistent with project critical path and respond appropriately to changing priorities
  • Facilitate smooth transfers of developed workflows into clinical lab environments
  • Evaluate emerging molecular and sequencing technologies and align these to business initiatives and product portfolio needs
  • Mentor scientific staff on experimental design, continuous learning, and time management
  • Conduct troubleshooting and quality control initiatives
  • Assist with the development of automated processes
  • Provide flexible support for other activities in the clinical Next Generation Sequencing lab

Tempus Labs, Inc. is a leader in precision medicine, leveraging artificial intelligence to analyze vast clinical and molecular data, enabling physicians to deliver personalized, data-driven care. The company's advanced machine learning platform and unique solution sets facilitate the discovery, development, and delivery of optimized therapeutic options for patients. With a focus on extensive molecular profiling, Tempus has developed a robust pan-cancer tumor organoid platform and validated a liquid biopsy assay, demonstrating their commitment to transforming personalized patient care and their position at the forefront of the healthcare industry.

Company Stage

Series G

Total Funding

$1.3B

Headquarters

Chicago, Illinois

Founded

2015

Growth & Insights
Headcount

6 month growth

5%

1 year growth

32%

2 year growth

52%